Growth Hormone Treatment on Atherosclerosis: Results of a 5-Year Open, Prospective, Controlled Study in Male Patients with Severe Growth Hormone Deficiency

Author:

Colao Annamaria1,Di Somma Carolina1,Spiezia Stefano2,Savastano Silvia1,Rota Francesca1,Savanelli Maria Cristina1,Lombardi Gaetano1

Affiliation:

1. Department of Molecular and Clinical Endocrinology and Oncology (A.C., C.D.S., F.R., M.C.S., G.L., S.Sa.), “Federico II” University of Naples

2. Emergency Unit (S.Sp.), “S. Maria degli Incurabili” Hospital of Naples, 80131 Naples, Italy

Abstract

Background: Severe GH deficiency (GHD) is associated with, increased cardiovascular risk and intima-media thickness (IMT) at major arteries.Objective: The objective of the study was to investigate the 5-yr effects of GH replacement on common carotid IMT and insulin resistance syndrome (IRS) (at least two of the following: triglycerides levels ≥ 1.7 mmol/liter, high-density lipoprotein-cholesterol levels ≤ 1.0 mmol/liter, blood pressure above 130/85 mm Hg, fasting glucose 6.1–7 or 2 hr after glucose 7.7–11.1 mmol/liter).Design: This was an interventional, open, prospective, controlled study.Patients: Patients included 35 men with severe GHD and 35 age-matched healthy men as controls.Intervention: All patients received standard replacement therapy; GH replacement was added in 22 patients (group A) and refused by 13 others (group B).Measurements: Five-year changes in IMT and IRS prevalence were measured.Results: At baseline, IMT was higher in the patients with (P < 0.001) and without IRS (P = 0.004) than in controls. Eighteen patients (51.4%) and two controls (5.7%; P < 0.0001) had IRS. At study end, use of lipid-lowering drugs (92.3, vs. 13.6 and 34.3%, P < 0.0001), glucose-lowering drugs (69.2 vs. 31.4 and 22.7%; P = 0.016), and antihypertensive drugs (61.5 vs. 20.0 and 4.5%; P < 0.0001) was higher in group B patients than controls and group A patients. IGF-I levels normalized in all group A patients and remained lower than −1 sd score in 77% of group B patients. IMT significantly decreased only in group A and significantly increased in controls and nonsignificantly in group B patients. IRS prevalence significantly reduced only in group A patients.Conclusions: Severely hypopituitary GHD men have more frequently increased IMT at common carotid arteries and IRS than controls. After 5 years, only in GH replaced patients, IMT and prevalence of IRS decreased.

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference47 articles.

1. Premature mortality due to cardiovascular disease in hypopituitarism.;Rosen;Lancet,1990

2. Increased cerebrovascular mortality in patients with hypopituitarism.;Bülow;Clin Endocrinol (Oxf),1997

3. The effect of hypopituitarism on life expectancy.;Bates;J Clin Endocrinol Metab,1996

4. Premature mortality in 1014 patients with hypopituitarism.;Tomlinson;Lancet,2001

5. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy;Colao;Growth Horm IGF Res,2006

Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3